Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Sunitinib malate market , by Region, 2019-2027 (USD Billion)
1.2.2. Sunitinib malate market , by Type, 2019-2027 (USD Billion)
1.2.3. Sunitinib malate market , by Application, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Sunitinib malate market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Sunitinib malate market Dynamics
3.1. Sunitinib malate market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of pancreatic cancer
3.1.1.2. Increasing prevalence of pancreatic neuroendocrine tumours
3.1.2. Market Restraint
3.1.2.1. High cost of Sutent
3.1.3. Market Opportunities
3.1.3.1. Increase in Pharmaceutical R&D Spending
Chapter 4. Global Sunitinib malate market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Sunitinib malate market , by Type
5.1. Market Snapshot
5.2. Global Sunitinib malate market by Type , Performance - Potential Analysis
5.3. Global Sunitinib malate market Estimates & Forecasts by Type 2018-2027 (USD Billion)
5.4. Sunitinib malate market , Sub Segment Analysis
5.4.1. Purity: >99%
5.4.2. Purity: >98%
5.4.3. Purity: >97%
Chapter 6. Global Sunitinib malate market , by Application
6.1. Market Snapshot
6.2. Global Sunitinib malate market by Application, Performance - Potential Analysis
6.3. Global Sunitinib malate market Estimates & Forecasts by Application 2018-2027 (USD Billion)
6.4. Sunitinib malate market , Sub Segment Analysis
6.4.1. Pancreatic Neuroendocrine Tumors
6.4.2. Kidney Cancer
6.4.3. Gastrointestinal stromal tumor
Chapter 7. Global Sunitinib malate market , Regional Analysis
7.1. Sunitinib malate market , Regional Market Snapshot
7.2. North America Sunitinib malate market
7.2.1. U.S. Sunitinib malate market
7.2.1.1. Type breakdown estimates & forecasts, 2018-2027
7.2.1.2. Application breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Sunitinib malate market
7.3. Europe Sunitinib malate market Snapshot
7.3.1. U.K. Sunitinib malate market
7.3.2. Germany Sunitinib malate market
7.3.3. France Sunitinib malate market
7.3.4. Spain Sunitinib malate market
7.3.5. Italy Sunitinib malate market
7.3.6. Rest of Europe Sunitinib malate market
7.4. Asia-Pacific Sunitinib malate market Snapshot
7.4.1. China Sunitinib malate market
7.4.2. India Sunitinib malate market
7.4.3. Japan Sunitinib malate market
7.4.4. Australia Sunitinib malate market
7.4.5. South Korea Sunitinib malate market
7.4.6. Rest of Asia Pacific Sunitinib malate market
7.5. Latin America Sunitinib malate market Snapshot
7.5.1. Brazil Sunitinib malate market
7.5.2. Mexico Sunitinib malate market
7.6. Rest of The World Sunitinib malate market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Pfizer Incorporation
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Topcarepharm
8.2.3. Njfirstpharm
8.2.4. J&K Scientific
8.2.5. Targetmol
8.2.6. Synthland Ltd
8.2.7. Teva Pharmaceutical Industries Ltd.
8.2.8. Astellas Pharma, Inc.
8.2.9. Dendreon Corporation
8.2.10. Ferring Pharmaceuticals, Inc.
Chapter 9. Research Application
9.1. Research Application
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption